A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia CellsPatricia Martin‐Rodríguez, Leandro Fernández‐Pérez|Frontiers in Pharmacology|2019Cited by 12